Artefact vs Zühlke: full comparison for 2026
Quick verdict
Artefact (4.2/5) edges ahead of Zühlke (4.0/5) overall. Artefact is the better choice for large consumer brands across European markets. Zühlke is the stronger option for swiss and European health and finance firms. The right choice depends on how independent you need the advice to be, your regulatory exposure, and your budget.
Artefact vs Zühlke: head-to-head summary
| Criterion | Artefact | Zühlke |
|---|---|---|
| Founded | 2014 | 1968 |
| HQ | Paris, France | Schlieren, Switzerland |
| Team size | 1,700+ | ~1,600 |
| Rating | 4.2 / 5 | 4.0 / 5 |
| Primary differentiator | Data governance and AI planning with engineers in the same firm | Partner-owned advisory and engineering for regulated health and finance work |
| Pricing model | Consulting fees; rates not published | Consulting and project fees; rates not published |
| Min. engagement | Not disclosed | Not disclosed |
| Primary tech stack | EU AI Act, GDPR, Google Cloud | EU AI Act, GDPR, Azure |
| Industries served | Consumer goods, Retail, Luxury, Financial services, Telecom | Healthcare, Medical devices, Banking, Insurance, Manufacturing |
Artefact vs Zühlke: overview
Artefact
Since its founding in Paris in 2014, Artefact has grown to more than 1,700 people in 25 countries. Cinven bought a majority stake in 2025 at a valuation above €1 billion, and the firm plans to triple in size by 2030, partly through acquisitions. Its advisory partners handle data governance and AI planning for large consumer brands. The same firm then builds, which is efficient but less neutral than a pure adviser.
Zühlke
Zühlke was founded in Switzerland in 1968, is headquartered in Schlieren near Zurich, and is owned by its partners. Directory figures put it at about 1,600 people across Europe and Asia. Its data and AI consultants work on strategy, governance, and responsible AI, mostly for health and financial clients, and the same firm builds the resulting systems. Partner ownership means no private equity or parent company is pushing a sales agenda.
Services and capabilities: Artefact vs Zühlke
| Capability | Artefact | Zühlke |
|---|---|---|
| Readiness assessment | ✗ | ✓ |
| Use-case prioritization | ✓ | ✗ |
| TCO / ROI modeling | ✗ | ✗ |
| AI governance & EU AI Act | ✓ | ✓ |
| Build vs. buy advice | ✗ | ✗ |
| Independent audit or assurance | ✗ | ✗ |
| Roadmap any vendor can implement | ✗ | ✗ |
| Delivery capability after advice | ✓ | ✓ |
Frameworks and platforms: Artefact vs Zühlke
| Framework / platform | Artefact | Zühlke |
|---|---|---|
| EU AI Act | ✓ | ✓ |
| GDPR | ✓ | ✓ |
| DORA | N/A | N/A |
| NIST AI RMF | N/A | N/A |
| ISO/IEC 42001 | N/A | N/A |
| Azure | ✓ | ✓ |
| AWS | N/A | ✓ |
| Google Cloud | ✓ | N/A |
Pricing comparison: Artefact vs Zühlke
| Criterion | Artefact | Zühlke |
|---|---|---|
| Minimum engagement | Not disclosed | Not disclosed |
| Engagement models | Multi-use-case advisory, Ongoing advisory, Delivery team | Fixed-scope assessment, Multi-use-case advisory, Delivery team |
| Rate transparency | Not public | Not public |
| Price tier | Mid-market | Mid-market |
Target audience comparison: Artefact vs Zühlke
| Dimension | Artefact | Zühlke |
|---|---|---|
| Best company size | Mid-market to enterprise | Mid-market to enterprise |
| Best industries | Consumer goods, Retail, Luxury | Healthcare, Medical devices, Banking |
| Best use cases | Data governance before scaling marketing AI., AI planning for a consumer brand in many EU markets. | Responsible AI planning for a medical-device maker., AI governance at a Swiss bank or insurer. |
| Typical project type | Multi-use-case advisory | Fixed-scope assessment |
Artefact vs Zühlke: pros and cons
| Artefact | |
|---|---|
| + | Data governance is a core practice |
| + | Advisers and engineers share one firm |
| + | Present in 25 countries |
| - | Majority-owned by Cinven since 2025, with acquisition-led growth ahead |
| - | Advice tends to lead to its own delivery work |
| - | Best suited to large brands |
| Zühlke | |
|---|---|
| + | Partner-owned, with no investor or parent shaping priorities |
| + | Long experience with medical-device and financial regulation |
| + | Advice and engineering in one firm |
| - | Swiss rates are high |
| - | Advice usually leads into its own delivery |
| - | Headcount figures come from directories |
Who should choose Artefact?
A typical fit: data governance before scaling marketing AI.
Data governance and AI planning with engineers in the same firm. Minimum engagement is not publicly disclosed. Works best with clients in Consumer goods, Retail, Luxury, Financial services, Telecom.
Who should choose Zühlke?
A typical fit: responsible AI planning for a medical-device maker.
Partner-owned advisory and engineering for regulated health and finance work. Minimum engagement is not publicly disclosed. Works best with clients in Healthcare, Medical devices, Banking, Insurance, Manufacturing.
Decision matrix: Artefact vs Zühlke
| Your situation | Recommended choice |
|---|---|
| You want advice with no build contract attached | Neither; write the build as a separate decision |
| Finance needs run costs before approving anything | Neither lists cost modeling; ask for a sample |
| Some of your use cases may be high-risk under the EU AI Act | Both cover AI Act classification |
| You need an outside check on a system already built | Neither; use a dedicated auditor |
| You want the same firm to build what it recommends | Both can deliver |
| Your budget is at the lower end | Compare: Artefact (Not disclosed) vs Zühlke (Not disclosed) |
| You need advisers in many countries at once | Artefact |
Use case fit: Artefact vs Zühlke
| Use case | Artefact fit | Zühlke fit | Winner |
|---|---|---|---|
| Data governance before scaling marketing AI. | Strong | Limited | Artefact |
| AI planning for a consumer brand in many EU markets. | Strong | Limited | Artefact |
| Responsible AI planning for a medical-device maker. | Limited | Strong | Zühlke |
| AI governance at a Swiss bank or insurer. | Limited | Strong | Zühlke |
Verdict: Artefact vs Zühlke
Artefact (4.2/5) is the stronger overall choice for most AI Advisory projects. Data governance and AI planning with engineers in the same firm.
Zühlke (4.0/5) is worth a look if you need AI governance at a Swiss bank or insurer. If your situation matches that, Zühlke is a competitive option.
Related comparisons
Artefact vs Zühlke FAQ
Is Artefact better than Zühlke?
Artefact (4.2/5) scores higher overall, but "better" depends on your use case. Artefact's strongest advantage: data governance is a core practice. Zühlke's strongest advantage: partner-owned, with no investor or parent shaping priorities.
How do Artefact and Zühlke differ in pricing?
Artefact's pricing: consulting fees; rates not published. Zühlke's pricing: consulting and project fees; rates not published. Any hourly bands shown come from Clutch, not a published rate card, so a scoping call is still needed for a project quote.
Which is better for enterprise: Artefact or Zühlke?
Artefact is the larger team and typically the better enterprise-scale choice. For very large programmes, verify team size and compliance coverage directly with each firm before shortlisting.
What are the main differences between Artefact and Zühlke?
Artefact's primary differentiator is: data governance and AI planning with engineers in the same firm. Zühlke's primary differentiator is: partner-owned advisory and engineering for regulated health and finance work. They also differ in team size (1,700+ vs ~1,600), minimum engagement (Not disclosed vs Not disclosed), and primary industries served (Consumer goods, Retail vs Healthcare, Medical devices).
Verify all details directly with each firm before making a decision.